Landsberg Bennett & Dubbaneh’s ResMed RMD Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$5.8M	Sell	22,130 -318	-1%	-$87K	0.74%	30
2021 Q2	$5.53M	Buy	22,448 +529	+2%	+$111K	0.72%	34
2021 Q1	$4.26M	Sell	21,919 -304	-1%	-$61K	0.61%	43
2020 Q4	$4.72M	Sell	22,223 -36	-0.2%	-$7.18K	0.72%	36
2020 Q3	$3.84M	Sell	22,259 -1,125	-5%	-$208K	0.67%	40
2020 Q2	$4.4M	Buy	23,384 +1,059	+5%	+$173K	0.91%	28
2020 Q1	$3.35M	Sell	22,325 -2,046	-8%	-$326K	0.94%	37
2019 Q4	$3.77M	Sell	24,371 -77	-0.3%	-$11.1K	0.88%	38
2019 Q3	$3.27M	Buy	24,448 +12,610	+107%	+$1.65M	0.88%	39
2019 Q2	$1.47M	Buy	+11,838	New	+$1.31M	0.38%	88

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's RMD Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its ResMed (RMD) stake by 1.4% in Q3 2021, selling an estimated $87K and leaving 22,130 shares worth $5.8M. The position accounts for 0.74% of the portfolio, ranked #30.

Landsberg Bennett & Dubbaneh first reported a position in RMD in Q2 2019 and has held it in 10 quarters since. 687 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

Landsberg Bennett & Dubbaneh held 22,130 shares of ResMed worth $5.8M as of Q3 2021.
Landsberg Bennett & Dubbaneh sold 318 ResMed shares in Q3 2021, an estimated $87K.
ResMed made up 0.74% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #30 holding.
Landsberg Bennett & Dubbaneh first reported a position in ResMed in Q2 2019 and has held it in 10 quarters since.
687 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.